Black Diamond Therapeutics Inc
NASDAQ:BDTX
Wall Street
Price Targets
BDTX Price Targets Summary
Black Diamond Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for BDTX is 13.06 USD with a low forecast of 10.1 USD and a high forecast of 16.8 USD.
BDTX Last Price Targets
Black Diamond Therapeutics Inc
The latest public price target was made on Apr 8, 2024 by Robert Driscoll from Wedbush , who expects BDTX stock to rise by 117% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Analyst | Price Target | Date | Article |
---|---|---|---|
Robert Driscoll
Wedbush
|
16
USD
Upside 117% |
4 weeks ago
Apr 8, 2024
|
Black Diamond Therapeutics (BDTX) PT Raised to $16 at Wedbush
StreetInsider
|
Raghuram Selvaraju
H.C. Wainwright
|
12
USD
Upside 62% |
1 month ago
Mar 18, 2024
|
Black Diamond Therapeutics (BDTX) PT Raised to $12 at H.C. Wainwright
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BDTX's stock price target?
Price Target
13.06
USD
According to Wall Street analysts, the average 1-year price target for BDTX is 13.06 USD with a low forecast of 10.1 USD and a high forecast of 16.8 USD.